BRAF(V600E) immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells: A STROBE-Compliant article

Treatment of BRAF(V600E)-mutant melanoma by small molecule inhibitors that target BRAF or MEK kinases is increasingly used in clinical practice and significantly improve patient outcome. However, patients eventually become resistant and therapeutic improvement is required. Molecular diversity within...

Descripción completa

Detalles Bibliográficos
Autores principales: Verlinden, Ivana, van den Hurk, Karin, Clarijs, Ruud, Willig, Arjan P., Stallinga, Cecile M.H.A., Roemen, Guido M.J.M., van den Oord, Joost J., zur Hausen, Axel, Speel, Ernst-Jan M., Winnepenninckx, Véronique J.L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2014
Materias:
4000
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603111/
https://www.ncbi.nlm.nih.gov/pubmed/25526463
http://dx.doi.org/10.1097/MD.0000000000000285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603111/
https://www.ncbi.nlm.nih.gov/pubmed/25526463
http://dx.doi.org/10.1097/MD.0000000000000285

Ejemplares similares